– Fauna Bio is an Emeryville, California-based biotechnology company leveraging animal genomics to improve human health.
– The company raised $9m in Seed funding.
– The round was led by LifeForce Capital with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and Arcadia Science.
– The new investment will be used to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.

– Nomad Health, the leading digital marketplace for temporary healthcare jobs, announced the completion of $63m in new equity and debt financing.
– Adams Street Partners led, and all existing investors participated, including Icon Ventures, Polaris Partners, RRE Ventures, .406 Ventures, First Round Capital, and Silicon Valley Bank.
– With this financing, the business has raised over $100m since the company’s inception in 2015.
– The funding will be used to support Nomad Health’s explosive growth, allowing the company to double down on efforts to hire, invest in the technology platform, and grow its national footprint.
– As the demands on the healthcare system have reached historic levels during the COVID-19 pandemic, the need and urgency for temporary healthcare staffing solutions has substantially increased.

– TurningPoint Healthcare Solutions, a Lake Mary, Fla.-based leader in advanced clinical and technology-enabled complex care management, received a growth funding of undisclosed amount.
– The round was led by Summit Partners, with participation from Oak HC/FT and existing investor Sopris Capital.
– The new investment will enable the company to expand into areas of healthcare, enhance its innovative technology and product offering, and expand its geographic presence.

– DotCom Therapy (DCT), the most comprehensive pediatric teletherapy provider, announced that it has raised $13 million in Series A funding to drive the expansion of its pediatric teletherapy resources, especially within healthcare systems nationwide.
– The expansion will help to address the dire widespread shortage of professional therapists and mental health resources in that sector.
– The financing was led by New Capital Partners with participation from LRVHealth and OSF Ventures.

– DotCom is a Madison WI-based pediatric teletherapy provider.
– Company raised $13m in Series A funding.
– The round was led by New Capital Partners with participation from LRVHealth and OSF Ventures, Will Cowen, general partner of LRVHealth, Stan Lynall, James Outland, Mark Bakken, Dr. Colleen Kraft and Rachel Mack Robinson.
– The new investment will be used to advance the features and functionality of its proprietary technology, Zesh, grow its customer base of schools across the country, and scale its partnerships with providers and payers in the healthcare industry.

– Wellbe Inc. from Madison develops a wellness platform to help consumers and employers manage their healthcare.
– Company raised $2m in Series A funding.
– The round was led by HealthX Ventures with co-investment by WISC Partners.
– The new investment will be aimed at accelerating product innovation and expansion into new markets, continuing focus on client service and platform usability.

– Doctor Anywhere from Singapore develops a tech-led healthcare company.
– The company raised US$65.7M in Series C funding.
– The round was led by Asia Partners and also joined by Novo Holdings A/S, Philips Venture, OSK-SBI Ventures and existing investors Square Peg, EDBI, IHH Healthcare, Kamet Capital and Pavilion Capital.
– The new investment will be used to bolster the company’s market leadership, to further deepen its presence in its existing markets, and to expand into new markets.

– SCAN Group, whose holdings include SCAN Health Plan, one of the nation’s largest not-for-profit Medicare Advantage plans, has made a strategic investment in MedArrive.
– MedArrive is a healthcare logistics and services platform that enables payers and providers to leverage a network of EMTs, paramedics and other types of skilled healthcare workers to extend care services into the home, improving patient outcomes while empowering an underutilized segment of the healthcare workforce.

– Covera Health announced its Series C financing.
– The $25m funding was led by global venture capital and private equity firm Insight Partners with participation from existing investors including Equity Group Investments.
– The round enables Covera to not only meet the growing demand for its healthcare quality insights, but also significantly expand its suite of innovative products supporting physicians and payers in their efforts to improve patient outcomes.
– Covera is solving one of the most impactful and challenging problems in healthcare today: ensuring patients get the right diagnosis at the right time, which gives them the best chance of a successful health outcome.

– Quiet Capital led the round with Mucker Capital, Fika Ventures, Tau Ventures, Global Founders Capital and SaaS Venture Capital also participating.
– HeyRenee is the latest innovation from Dr. Renee Dua and Nick Desai, co-founders of Heal who spent seven years building the award-winning home-centric primary care company.
– HeyRenee is a uniquely patient-centric digital health platform designed to make better healthcare a reality for all Americans, especially the elderly, underserved, and those managing chronic conditions.
– HeyRenee will eventually work with every provider, partner, and point solution to curate the perfect combination of services for each patient’s specific needs.

– Telehealth company Lucid Lane raised $16m in Series A funding.
– The funding was led by Accel Partners and joined by other investors.
– The company plans to use the funding to continue developing its platform that enables real-time intervention for people with medication dependence and substance-use disorders.

– Cayaba Care, a maternal health company offering community-based clinical services via technology-enabled multidisciplinary care teams, announced the closing of $3.2m in seed capital.
– Cayaba Care’s technology-enabled, community-based care model addresses current gaps in maternity care for women experiencing social and health inequities.
– By utilizing technology, Cayaba Care can improve access for patients, identify timely interventions, and improve overall health outcomes.
– As part of a sweeping action plan in response to the tragic rate of maternal deaths, on December 3, 2020, the US Department of Health and Human Services (HHS) announced its intention to reduce maternal mortality by 50% by 2025.
– Recent statistics reveal extraordinary inequities, with Black and Hispanic women facing three to four times the rate of pregnancy-related morbidity and mortality.

– Carefeed closed a venture financing round.
– The round was led by Allos Ventures with participation by M25.
– Carefeed will expand its footprint in skilled nursing and senior living communities across the United States and Canada, enhance its digital communication platform, and broaden its offerings into other patient care settings.

– Eyenuk, a Los Angeles CA-based artificial intelligence (AI) medical technology and services company, raised $6.2M in funding.
– The round was led by AXA IM, through AXA IM Alts.
– The company intends to use the funds to accelerate commercialization of the EyeArt® AI System.

– Even, a healthcare membership company, raised $5m in seed funding.
– The round was led by Khosla Ventures, with participation from Founders Fund, Lachy Groom and a group of individuals including Palo Alto Networks CEO Nikesh Arora, CRED CEO Kunal Shah, Zerodha founder Nithin Kamath and DST Global partner Tom Stafford.
– The company aims to cover what most insurance companies in the country don’t, including making going to a primary care doctor as easy and accessible as it is in other countries.

– Fetch Package, an Austin, Texas-based last-mile package delivery service for apartment communities, raised $60m in funding.
– The $50m Series C equity funding round was led by Ocelot Capital with participation from Greenpoint Partners, Alpaca VC and Rose Park Advisors and existing investors Iron Gate Capital, Signal Peak Ventures, Venn Ventures, Pando Ventures, and Seamless.
– The company intends to use the funds to continue to scale its business by opening in 24 new major markets over the next two years as well as continuing to expand to new locations within existing markets.

– ProciseDx from San Diego develops rapid diagnostic tests for the physician’s office.
– The company raised $13M in convertible note financing.
– The round was led by existing major shareholders (Nestlé Heath Science, Biosynex SA) management and new investors.
– The company intends to use the funds to move forward with FDA submissions for the platform and to expand the test menu for gastroenterologists.

– RVH Solutions, Inc. is a New York-based healthcare technology company.
– The company raised an undisclosed amount in Series B funding.
– The round was led by Vizient.
– The new investment will be used to accelerate growth, expand operations and its business reach.

– ComeBack Mobility is a medtech startup from Kyiv, Ukraine.
– Company raised $1M in seed funding.
– The round was led by Ukrainian medtech investment fund Fison with participation from Peter Chernyshov, the ex-CEO of the telecom KyivStar, the pharmaceutical company Farmak, and several angel investors from Ukraine, Belgium and the US.
– The new investment will help to develop products.

– Osso VR, a validated virtual reality (VR) surgical training and assessment platform, has secured $27M in Series B funding.
– GSR Ventures led the funding round with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures and Anorak Ventures.
– Osso VR’s surgical training technology provides on-demand, educational experiences that are effective, repeatable and measurable to help surgeons reach proficiency with emerging surgical techniques and technologies.

– Cortica from San Diego CA is focused on clinical services for autism and other neurodevelopmental conditions.
– Series C $60m funding round was led by Longitude Capital with participation from 406 Ventures, Adam Boehler, Questa Capital and Aperture Venture Partners and Silicon Valley Bank.
– The new financing will be used to accelerate growth, expand centers across multiple states, and investigate novel drug, device, and diagnostic technologies through sponsored and NIH-funded research.

– Wealthy, a New York-based digital care concierge platform that partners with employers to find care for employees and their families, raised $35M in Series B funding.
– The round was led by Rethink Impact with participation from Hearst, Polaris Partners, and Eldridge.
– The company intends to use the funds to grow and enhance its smart recommendations engine, advance its predictive support pathways, and launch an online community where families can exchange tips and ideas with other caregivers and gain insights from experts.

– AlayaCare, a global home and community care software company, announced a $225m CAD Series D funding round led by Generation Investment Management LLP with participation from Klass Capital and incumbent investors Inovia Capital, CDPQ, and Investissement Québec.
– The US is now the fastest-growing part of AlayaCare’s business, representing 7x growth in the last 24 months.
– AlayaCare will use the funding to continue global expansion, hire additional staff and further invest in innovation capabilities to build a more complete post-acute offering in addition to products that help solve labour market issues around employee shortages and churn.
– The transaction was supported by TD Securities Inc. as exclusive financial advisor, Aust Legal, and Stikeman Elliott LLP who acted as advisors for AlayaCare.

– Spiras Health announced a $14MM Series B funding round led by NEA, with participation from existing investors Altitude Ventures, FCA Venture Partners, and other strategic investors.
– The company will leverage the financing for new market launches, sales and marketing team build, R&D with technological development and strengthening its management team.
– Spiras Health is a provider of in-home and virtual healthcare solutions for patients with complex chronic conditions.
– The company has a refined clinical model for expansion into more markets with health plan partners.
– Their clinical teams address avoidable costs by bringing personalized services to the patient, increasing access, and improving quality of care through a highly efficient and scalable delivery model.

– BEKHealth is a Stamford, Conn.-based AI-powered clinical research software platform.
– The company raised $4m in funding.
– The round was led by Excelerate Health Ventures with participation from syndicate partners Boston Millennia Partners, Connecticut Innovations and Martin Ventures, as well as Change Healthcare.
– The new investment will be used to accelerate the company’s growth and expansion.

– Sempre Health, a San Francisco, CA-based provider of a behavior-based healthcare pricing solution, closed a $15M Series B financing.
– The new investment was led by the Blue Venture Fund – a collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, with participation from UPMC Enterprises and existing investors Rethink Impact, LifeForce Capital and Industry Ventures.
– The company intends to use the funds to advance its two-sided network of payors and pharma manufacturers nationwide and further grow the number of chronic disease patients Sempre can help access their medications.

– The Pill Club, a birth control prescription and delivery service, raised $41.9m in Series B extension funding.
– The round was led by Base 10 and joined by existing investors, including ACME, GV, Shasta Ventures and VMG, as well as new investors, including Uber’s Dara Khosrowshahi and Honey’s George Ruan and iGlobe.
– The extension round comes over two years after the company announced its initial Series B investment, a $51m financing.
– The company declined to provide its latest valuation, other than saying that the extension was an up-round.

– Owl Peak Lab is a Charlottesville VA-based company focused on developing screening solutions to detect colorectal cancer.
– The company raised $1.5M in seed funding.
– The round was led by undisclosed investors.
– The new investment will be used to further develop novel imaging technology to detect anomalies of the gastrointestinal tract at the earliest stage and to invest in its Artificial Intelligence platform to aid in early detection.

– Owl Peak Labs announced the fully subscribed closure of its seed round of $1.5 million.
– The funding will be used to further develop innovative diagnostic solutions using Owl Peak Labs’ novel imaging technology to detect anomalies of the gastrointestinal tract at the earliest stage.
– Owl Peak Labs will also continue to invest in its Artificial Intelligence platform to aid in early detection.
– Colorectal cancer is known as the least prevented, though most preventable, cancer, accounting for 10% of cancer cases but second overall in cancer deaths.
– Only 64% of Americans undergo recommended routine screening, well below the CDC’s 80% goal, contributing to over 53,000 deaths in the United States each year.

– Monogram Health is a Nashville TN-based kidney disease benefit management and care delivery company.
– Company raised $160m in Series B funding.
– The round was led by TPG Capital, the private equity platform of global alternative asset firm TPG, with participation from existing investors Frist Cressey Ventures and Norwest Venture Partners, as well as Humana Inc. and other notable national and regional strategic investors.
– The new funding will be used to accelerate business expansion.

– Lifted, a U.K. startup, raised $6.2m in Series A funding.
– The round was led by Fuel Ventures and joined by 1818 Venture Capital, Novit Ventures, Perivoli Innovations, the J.B. Ugland family office and a number of angels.
– The company plans to use the funding to expand its operations in the U.K.
– It also acquired the “Live Better With Dementia” website and launched the Lifted Dementia Hub, an online community with a marketplace of products.

– Medallion has raised a $20M Series A with Spark Capital and Optum Ventures.
– Other participating investors in the round include BoxGroup, Susa Ventures, Tom Lee, Joe Montana, Elad Gil, Zach Sims, Daniel Gross, Peter Reinhardt, Nat Friedman, Vivek Ramaswamy; and the founders of Ro, PillPack, Carbon Health, Nurx.

– Sera Prognostics, Inc. from Salt Lake City develops a blood-based biomarker test to predict the risk of preterm birth.
– Series E $100m round brings company valuation to more than $1b.
– The round was led by Vivo Capital, aMoon Fund, Parian Global and others, with participation from existing investors Anthem, Inc., and Blue Ox Healthcare Partners.
– The new investment will be aimed at commercializing its PreTRM® testing, accelerating the development of its pipeline of biomarker tests to predict other major conditions of pregnancy, and developing testing capacity for over 3 million annual pregnancies that are candidates for its PreTRM® Test in the United States.

– Eleanor Health, an outpatient addiction and mental health provider, has closed an oversubscribed $20M Series B financing.
– The company received participation from all existing investors including Town Hall Ventures, Echo Health Ventures, and Mosaic Health Solutions, as well as new participation from Warburg Pincus.

– Health technology pioneer DrFirst announced the closing of a $50 million equity investment from Sixth Street Growth, the growth investing platform of Sixth Street, a leading global investment firm.
– Following Sixth Street’s previous $35 million investment and another $50 million from Goldman Sachs Growth, both in 2020, DrFirst’s investment total over the past year is now $135 million.
– DrFirst solutions are used by nearly 300,000 healthcare professionals, including more than 100,000 prescribers, nearly half of the electronic health record (EHR) systems in the U.S., and more than 1,400 hospitals in the U.S. and Canada.
– The company’s sustained business growth, long-standing work with leading health systems, expanding customer base, and proven leadership in the digital health solutions market underscore the investments.

– 1upHealth has raised a $25m Series B led by F-Prime Capital.
– Existing investors, Jackson Square Ventures (which led our Series A), Eniac Ventures, and Social Leverage also participated.
– The infusion of capital will help us grow and evolve our FHIR connectivity & compute platform that’s already used by dozens of health plans, providers, app developers, and pharma companies.
– When we started selling for CMS compliance, we only had 15 team members. A year later, we are 70 strong, with dozens of health plans and states using our infrastructure and API platform.
– We’re now supporting 11 million of patients through dozens of health plan and provider customers.
– With this new round of capital, we’re positioned for rapid growth.

– Caresyntax from Boston is a digital surgery platform that provides actionable insights to improve patient outcomes.
– The company closed a $100m Series C funding.
– The round was led by PFM Health Sciences LP and included participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, as well as current investors IPF Partners, the Relyens Group, and Surgical.
– The new investment will be used to accelerate the company’s global expansion and development of new products.

– CareRev from Venice, CA provides a platform for healthcare professionals to find and fill shifts at hospitals and other healthcare facilities.
– The company raised $50m in Series A funding.
– The round was led by Transformation Capital with participation from Industry Ventures and Zach Coelius, Michael Siebel, Gaingels and others.
– The new investment will be used to scale operations, including incorporating more AI and machine learning.

– CirrusMD from Denver, CO provides on-demand virtual care services.
– The company raised $20m in Series C funding.
– The round was led by Blue Venture Fund, with participation from 7wireVentures, Drive Capital and the Colorado Impact Fund.
– The new investment will be used to continue to expand solution capabilities, enhance user and provider experiences, increase scalability, and drive innovation to support employer and health plan customers.

– Crossover Health has secured $168m in Series D financing led by Deerfield Management Company.
– The capital will be applied to continuing the national expansion of Crossover’s Connected System of Health for employers and payers.
– Crossover Health is a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for employers and health plans.
– Goldman Sachs & Co. LLC acted as the exclusive placement agent for the financing and Latham & Watkins LLP served as legal counsel to Crossover Health.

– Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
– Ro is the healthcare technology company
– The company has completed a $500 million Series D fundraising round led by existing investors General Catalyst, FirstMark Capital and TQ Ventures, with significant participation from existing investors SignalFire, Torch Capital and BoxGroup as well as new investors Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.
– The Series D brings Ro’s total fundraising since its founding in 2017 to $876 million.
– Ro will use the newly-raised capital to strengthen its vertically integrated primary care platform.

– MedMinder Systems Inc. a Needham, MA-based fully-integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients, raised $40m in funding.
– The round was led by Accelmed Partners with participation from Arkin Holdings and existing investors.
– The company intends to use the funds to expand its connected care and telehealth offering, scale its commercial operations by opening additional automated pharmacy locations in high-density metropolitan areas across the U.S., and expand its management, sales and marketing teams with strategic hires.

– Accelmed Partners, a private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies, today announced that it led a $40m investment in MedMinder Systems Inc.
– The investment was led by Accelmed and includes participation from the company’s executive leadership, NewView Capital and Georgian Partners.
– MedMinder is uniquely positioned to meet the needs of elderly and chronically ill patients who require more comprehensive pharmacy service and better engagement with clinical teams.
– MedMinder’s touch screen-enabled, automatic pill dispenser is the first solution on the market capable of delivering medications from its pharmacy directly to patients’ doors in pre-organized daily trays for the entire month.
– MedMinder empowers thousands of patients to live more independently in their homes while improving their adherence to prescribed medications.

– DexCare announces $20m Series A funding led by Define Ventures and including Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures and Providence Ventures.
– DexCare is an intelligent digital care operating system that manages health system capacity and demand across all lines of care.
– DexCare has secured half a dozen customers, including Community Health Network, the Froedtert and the Medical College of Wisconsin health network, Houston Methodist, and Providence.
– Concurrent with funding, DexCare has been spun out as a separate company after being incubated at Providence within its Digital Innovation Group.
– Providence developed DexCare initially as the platform for Providence’s ambulatory care business.

– Gravie is a Minneapolis, MI-based defined contribution healthcare company.
– The company raised $28m in Series D funding.
– The round was led by AXA Venture Partners, with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners.
– The new investment will be used to accelerate the company’s growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels.

– Riva Health, a mobile cardiology app, today announced $15.5M in funding led by Menlo Ventures.
– UCHealth and University of Colorado Innovation Fund also participated in the round, as well as leading Chicago healthcare investors, Brandon Cruz of GoHealth and Larry Gies of Madison Industries.
– This investment follows on the heels of a previous round led last year by Menlo Ventures, alongside True Ventures.
– Riva is led by CEO Dag Kittlaus, former co-founder of both Siri and Viv, and Tuhin Sinha, PhD and co-founder of one of the largest cardiovascular research studies in the world, Health eHeart.
– Dr. Rich Zane from UCHealth will join Greg Yap from Menlo Ventures on Riva’s board of directors.

– Strive Health, a Denver, CO-based value-based kidney care company, secured a $140m Series B funding round.
– The round was led by CapitalG with participation from Redpoint and current investors NEA, Town Hall Ventures, Ascension Ventures and Echo Ventures.
– The company intends to use the funds to expand its business reach.

– Marché Health, a trusted source for empowering better decisions around digital health, today announced $1m in seed funding from Pandion Optimization Alliance (Pandion).
– This strategic investment will be instrumental in scaling Marché Health’s digital health marketplace to enable organizations to adopt resources needed for meeting the quadruple aim of better outcomes, improved patient experience, improved clinician experience and lower costs.
– Sixty percent of U.S. adults have a chronic disease and these are the biggest contributors to the $3.5 trillion in annual healthcare costs.
– COVID-19 showed that many care plans can be enhanced through digital tools, including telehealth and remote patient monitoring, encouraging a flood of new solutions entering the market.
– The resulting confusion has delayed digital health adoption and hampered progress.

– Halo Diagnostics, a healthcare startup, raised $19m in Series A funding.
– The round was led by Khosla Ventures and joined by Founders Fund, and others.
– The company plans to use the funding to expand its facilities and services.

– Renalogic announced that it has received a significant investment from Carrick Capital Partners.
– Renalogic is the industry leader in dialysis risk management and cost containment.
– Renalogic has experienced unprecedented growth over the last three years by helping health plans and their members reduce risk associated with Chronic Kidney Disease.
– Renalogic takes a holistic approach to reducing risk associated with CKD, offering proven intervention for plans’ highest risk population, member education, patient advocacy, and dialysis cost containment.
– Renalogic recently launched an innovative predictive modeling and artificial intelligence platform, CareINSIGHTS.ai that enhances their high-touch, personalized intervention. Their ability to proactively address previously hidden CKD risk is a welcomed change to an industry that has struggled to reduce massive claims costs.

– Upward Health raised a significant equity financing led by Heritage Group, with participation from existing investors including Noro-Moseley Partners, the Blue Venture Fund and Windham Ventures.
– The company partners with health plans, taking on risk and guaranteeing outcomes in both cost and quality across their most complex and high-cost populations.
– The company pairs these members with care specialists who form trusted relationships and coordinate all aspects of the members’ care.
– Upward Health enables Facilitated Virtual Care™ visits with Upward Health providers and works to support and strengthen any existing member relationships with primary care physicians.

– WuXi Diagnostics secured a US$150m Series B financing round to accelerate market penetration in the global diagnostics sector.
– The round was joined by new investors including Thermo Fisher, Shiyu Capital, ABC International, Sunland Capital, and CCBI Tech Venture.
– WuXi Diagnostics will deploy funds to strengthen its open-access innovation enabling platform, advance its integrated diagnostics R&D pipeline, and accelerate market penetration in the global diagnostics sector.
– WuXi Diagnostics is the first platform company in China focusing on integrated diagnostics. Since its establishment in 2018, WuXi Diagnostics has continuously promoted the clinical practice of integrated diagnostics by virtue of its open-access innovation enabling platform, centered on multi-omics clinical data from multidisciplinary technologies.

– OmniLife has launched an open $250,000 CF round of investment through Wunderfund.co to enable the passionate organ donation community to participate in providing innovative solutions to the industry.
– Open to non-institutional, private investors with lower investment minimums and no accreditation requirements, the funds raised with this crowd-sourced opportunity will be used to support the commercialization of the company’s newest product, a communication-centric workflow tool allowing providers to collaborate on cases together to increase efficiency, transparency and coordination in order to place more organs and tissues and save more lives.
– Over the last four years, OmniLife has developed the largest collaboration and communication network specifically for transplant and donation professionals, with new organizations and partners joining every day.

– Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the cancer patient experience, has today announced the completion of a Series C equity investment of $18 million.
– The oversubscribed $18 million equity round was led by Philips Health Technology Ventures, and also includes Debiopharm Innovation Fund, and OurCrowd’s digital health fund, Qure Ventures, as well as prior investors HLM Venture Partners, LRVHealth, Cerner, and founder Madelyn Trupkin Herzfeld.

– Tele-Behavioral Health Service Valera Health Closes $3.8 Million
– The company raised $3.8m in Series A funding.
– The round was led by AXA Venture Partners (AVP) with participation from Windham Ventures, Figure Eight Investments, and notable mental health expert Tom Insel, MD (former Director of the National Institute of Mental Health).

– Equip, a health tech company pioneering a program that virtually delivers evidence-based eating disorder treatment to families at home, today announced it has closed $13m in Series A financing, bringing its total funds raised to date to $17m.
– The Series A round was led by Optum Ventures, with participation from new investor .406 Ventures and existing investor F-Prime Capital, who led the company’s prior Seed round.
– Equip’s mission is to make gold-standard eating disorder treatment accessible to all people through Family-Based Treatment (FBT) – the standard of care which empowers families to help their loved ones through recovery.

– MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round.
– MedLumics’ optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
– This round was led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II.
– MedLumics is now ready to initiate first in-human regulatory clinical studies and automate scalable product manufacturing.